environmental assessment of genetically engineered animals at cvm (fda) animal biotechnology...

14
Environmental Assessment of Genetically Engineered Animals at CVM (FDA) Animal Biotechnology Interdisciplinary Group Center for Veterinary Medicine U.S. Food and Drug Administration Evgenij A. Evdokimov, MS, PhD June 4, 2015

Upload: abigayle-austin

Post on 18-Jan-2016

220 views

Category:

Documents


2 download

TRANSCRIPT

Page 1: Environmental Assessment of Genetically Engineered Animals at CVM (FDA) Animal Biotechnology Interdisciplinary Group Center for Veterinary Medicine U.S

Environmental Assessment of Genetically Engineered Animals at CVM (FDA)

Animal Biotechnology Interdisciplinary GroupCenter for Veterinary Medicine

U.S. Food and Drug Administration

Evgenij A. Evdokimov, MS, PhD

June 4, 2015

Page 2: Environmental Assessment of Genetically Engineered Animals at CVM (FDA) Animal Biotechnology Interdisciplinary Group Center for Veterinary Medicine U.S

Major Statutes Governing Regulation of GE Animals

Federal Food, Drug, and Cosmetic Act (FD&C Act) Products are regulated; not processes GE animals are regulated under New Animal Drug

Provisions of the Act*

National Environmental Policy Act (NEPA) Procedural; major agency’s actions trigger NEPA

assessment

*Regulated article - article intended to affect the structure or function of the animal (e.g., rDNA construct)

Page 3: Environmental Assessment of Genetically Engineered Animals at CVM (FDA) Animal Biotechnology Interdisciplinary Group Center for Veterinary Medicine U.S

Guidance for Industry 187*

Regulated article = article intended to affect

the structure or function of the animal

(e.g., rDNA construct) Covers all types of GE animals All GE animals in a lineage are covered Event-based, case-by-case evaluation Enforcement discretion and approval paths New Animal Drug Application (NADA) means mandatory

approval prior to marketing Post-market surveillance

*http://www.fda.gov/AnimalVeterinary/DevelopmentApprovalProcess/GeneticEngineering/GeneticallyEngineeredAnimals/default.htm

Page 4: Environmental Assessment of Genetically Engineered Animals at CVM (FDA) Animal Biotechnology Interdisciplinary Group Center for Veterinary Medicine U.S

Are there significant direct or indirect effects from introduction of the GE animal into the environment?

Basis for satisfying NEPA requirements.

Hierarchical Risk-Based Evaluation

Page 5: Environmental Assessment of Genetically Engineered Animals at CVM (FDA) Animal Biotechnology Interdisciplinary Group Center for Veterinary Medicine U.S

Finding of No Significant Impact

(FONSI)

NEPA Process Overview

Regulated Article

May Significantly

Affect

Environmental Impact

Statement (EIS)

NoSignificant

Effects

Record of Decision (ROD)

Environmental Assessment (EA)

Page 6: Environmental Assessment of Genetically Engineered Animals at CVM (FDA) Animal Biotechnology Interdisciplinary Group Center for Veterinary Medicine U.S

BiologicalContainmentPhysical

Containment

Source(s)Escape or

Introduction

Able to Survive

Impact on Target Resources in the Environment

(habitats, wildlife)

Dispersion

Direct and Indirect Effects

Accessible Environments

Able to Reproduce

Establishment

Spread of Transgene(s)

Wild Conspecifics

Feral Relatives

Net Fitness

Geographical/ Geophysical Containment

Conceptual Framework for Environmental Assessment

??

?

Page 7: Environmental Assessment of Genetically Engineered Animals at CVM (FDA) Animal Biotechnology Interdisciplinary Group Center for Veterinary Medicine U.S

Environmental Assessment: General Risk Questions

For a specific GE animal (population) containing a specific regulated article….

– What is the intent (free release or contained use)?• If contained use - what is the likelihood of escape?

– What is the likelihood of survival in the receiving environment?

– What is the likelihood of establishment and reproduction?– What are potential consequences/effects to the environment

associated with introduction/inadvertent release?

Considered in context of an appropriate comparator on a case-by-case basis

Page 8: Environmental Assessment of Genetically Engineered Animals at CVM (FDA) Animal Biotechnology Interdisciplinary Group Center for Veterinary Medicine U.S

Potential Environmental Hazards and Harms

Hazard Harm

Does the rDNA construct introduce any hazardous elements into the animal (e.g., viral or mobilizable sequences, sequencing encoding pathogens or toxins, vectors) (Characterized in Molecular Characterization steps)

Increased probability of new pathogenic recombinants

Do introduced traits affect species fitness or adaptation(Characterized in Phenotypic Characterization)

Increased probability of disruption of existing ecosystems due to establishment of a GE animal in the environment

Page 9: Environmental Assessment of Genetically Engineered Animals at CVM (FDA) Animal Biotechnology Interdisciplinary Group Center for Veterinary Medicine U.S

Fitness

• Fitness affects survival and reproduction

• Net fitness components include– Juvenile and adult viability – Age at sexual maturity – Female fecundity/male fertility/mating success

Page 10: Environmental Assessment of Genetically Engineered Animals at CVM (FDA) Animal Biotechnology Interdisciplinary Group Center for Veterinary Medicine U.S

Impacts

• Pathogen / disease transfer• Genetic disturbance• Resource competition• Displacement• Habitat destruction• Predation

Population changes

Community/Ecosystem disruptions

Page 11: Environmental Assessment of Genetically Engineered Animals at CVM (FDA) Animal Biotechnology Interdisciplinary Group Center for Veterinary Medicine U.S

Consequences of Introduction, Escape, and Dispersion

Will depend largely on:• Specific physical locations of production or release;

• Extent of containment (if applicable);– Physical/mechanical– Biological (e.g., sterility, monosex)– Geographical/geophysical (environmental conditions)– Domestication of species (ability to become feral)

• Mobility of species

Page 12: Environmental Assessment of Genetically Engineered Animals at CVM (FDA) Animal Biotechnology Interdisciplinary Group Center for Veterinary Medicine U.S

Areas of interest

Potential risks associated with introduction of GE animals into the environment that are function of the introduced trait

– Longevity;– Mating behavior;– Stability of genotype and phenotype over time;

Page 13: Environmental Assessment of Genetically Engineered Animals at CVM (FDA) Animal Biotechnology Interdisciplinary Group Center for Veterinary Medicine U.S

Areas of interest

• Do we always need containment for GE animals?

– GE terrestrial livestock intended for food use?– GE animals for population control?– GE animals receiving gene therapy treatment?

• What risks do we guard against?

• Is gene flow a risk per se?

Page 14: Environmental Assessment of Genetically Engineered Animals at CVM (FDA) Animal Biotechnology Interdisciplinary Group Center for Veterinary Medicine U.S

Questions?

Contacts at CVM:

Dr. Evgenij Evdokimov [email protected]